Dublin, April 17, 2025 (GLOBE NEWSWIRE) — The “Single Cell Analysis Market Size, Share & Trends by Product (Consumables (Beads, Kits, Reagents), Instruments), Cell Type (Human, Animal), Technique (Flow Cytometry, NGS, PCR, Microscopy), Application (Research (Cancer, Neurology), Medical (NIPT, IVF)) – Global Forecast to 2029” has been added to ResearchAndMarkets.com’s offering.
The single-cell analysis market is poised for significant growth, anticipating an increase from USD 3.7 billion in 2024 to USD 6.9 billion by 2029, at a Compound Annual Growth Rate (CAGR) of 13.6%. This growth trajectory is largely fueled by burgeoning interest in personalized medicine and rising R&D investments in the pharmaceutical and biotechnology sectors. Additionally, technological advancements and a surge in cancer cases are some pivotal factors driving market development, along with a steep rise in the adoption of advanced single-cell sequencing techniques.
Research Applications Lead in 2023
In 2023, the research application segment dominated, driven by its utility in cancer, immunology, neurology, and stem cell research. The growing prevalence of cancer has heightened the demand for advanced therapeutic options that leverage single-cell analysis, resulting in substantial market uptake. Similarly, stem cell research advancements bolster this segment’s growth trajectory.
Flow Cytometry: A Technological Front-runner
Flow cytometry emerged as the leading technology segment in 2023, attributed to its comprehensive applicability in performing multifaceted measurements in heterogeneous mixtures. The technology’s widespread acceptance is further cemented by the persistent adoption of advanced methods for cell identification and characterization, thereby augmenting market expansion.
US Leads Regional Market Dynamics
The United States spearheads the global single-cell analysis market, capitalizing on its robust biopharmaceutical industry and substantial research funding. The healthcare infrastructure in the US, along with a strong presence of biopharmaceutical entities, significantly propels market growth. Moreover, the increasing focus on personalized medicine due to rising cancer incidences further strengthens its market dominance.
Research Methodology and Company Insights
Primary interviews conducted comprise 70% supply-side and 30% demand-side respondents, encompassing managers (45%), CXOs & directors (30%), and executives (25%), across regions like North America (40%), Europe (25%), and Asia-Pacific (25%). The report encompasses profiles of pivotal players including Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, and BD, among others.
Research Coverage
The report categorizes the market by products (consumables and instruments), cell type, technique, application, and region. It addresses major market drivers, challenges, and opportunities while offering insights into competitive landscapes and strategies of key companies. Additionally, it provides information on product launches, collaborations, and acquisitions within the single-cell analysis market.
Key Benefits of the Report
This comprehensive report offers close revenue approximations for the overall market and its subsegments, assisting market leaders and new entrants alike with competitor analysis and strategic positioning. It delivers insights into market drivers, constraints, opportunities, and industry challenges.
Insights Offered:
- Drivers: Technological advancements, cancer prevalence, and R&D growth in complex diseases.
- Restraints: High costs of single-cell products.
- Opportunities: Microfluidics integration.
- Challenges: Protocol standardization and data quality control.
- Product Innovations: Highlights on recent product launches and technological breakthroughs.
- Market Development: Analysis of lucrative markets across regions.
- Diversification: New products, geographies, and recent developments in single-cell analysis.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 492 |
| Forecast Period | 2024 – 2029 |
| Estimated Market Value (USD) in 2024 | $3.7 Billion |
| Forecasted Market Value (USD) by 2029 | $6.9 Billion |
| Compound Annual Growth Rate | 13.6% |
| Regions Covered | Global |
Market Dynamics
Drivers
- Technological Advancements in Single-Cell Analysis Products
- Rising Prevalence of Cancer
- Increasing R&D in Pharmaceutical and Biotechnology Industries
- Growth in Stem Cell Research
- Growing Focus on Personalized Medicine
Restraints
- High Cost of Single-Cell Analysis Products
Opportunities
- High Growth Potential of Single-Cell Sequencing
- Integration of Microfluidics in Single-Cell Analysis
- Rising Potential in Emerging Asian Markets
Challenges
- Lack of Standardization in Protocols and Quality Control Procedures
- Technical Limitations of Single-Cell Analysis
- Mounting Ethical and Privacy Concerns
Company Profiles
- Bd
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- 10X Genomics
- Merck KGaA
- Agilent Technologies, Inc.
- Qiagen
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Diasorin S.P.A.
- Standard Biotools
- Tecan Trading AG
- Sartorius AG
- Corning Incorporated
- Cytek Biosciences
- Takara Bio Inc.
- Biomerieux
- Revvity
- Bio-Techne
- Pacbio
- Bruker
- Promega Corporation
- Oxford Nanopore Technologies PLC
- Singleron Biotechnologies
- Cell Microsystems
- Nanocellect Biomedical
- Rarecyte, Inc.
- Bico
- Menarini Group
For more information about this report visit https://www.researchandmarkets.com/r/vljs0z
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Single Cell Analysis Market
